Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-14-3394PMID 26238785PMCID PMC4592465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

  2014cited by this paper
• A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

  2014cited by this paper
• Macrophage biology in development, homeostasis and disease

  2013cited by this paper
• Direct Proteomic Quantification of the Secretome of Activated Immune Cells

  2013cited by this paper
• Macrophage regulation of tumor responses to anticancer therapies.

  2013cited by this paper
• Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study

  2013cited by this paper
• Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm.

  2012cited by this paper
• Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort

  2012cited by this paper
• The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients

  2012cited by this paper
• Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer

  2012cited by this paper
• CCR5 antagonist blocks metastasis of basal breast cancer cells.

  2012cited by this paper
• Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

  2011cited by this paper
• CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis

  2011cited by this paper
• Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility

  2011cited by this paper
• Signalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer

  2011cited by this paper
• Tumor necrosis factor (TNF)‐α, soluble TNF receptors and endometrial cancer risk: The EPIC study

  2011cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization

  2009cited by this paper
• Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.

  2009cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target

  2008cited by this paper
• Granulin‐epithelin precursor as a therapeutic target for hepatocellular carcinoma

  2008cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells

  2007cited by this paper
• Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

  2006cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells.

  2004cited by this paper
• Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis

  2003cited by this paper
• Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

  2003cited by this paper
• Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.

  2003cited by this paper
• Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results

  2003cited by this paper
• A chemokine receptor antagonist inhibits experimental breast tumor growth.

  2003cited by this paper
• Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival.

  2002cited by this paper
• Raf Kinase Inhibitor Protein Interacts with NF-κB-Inducing Kinase and TAK1 and Inhibits NF-κB Activation

  2001cited by this paper
• Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

  2001cited by this paper
• Both Extracellular Immunoglobin-like Domains of CD80 Contain Residues Critical for Binding T Cell Surface Receptors CTLA-4 and CD28 (*)

  1995cited by this paper
• Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.

  1988cited by this paper

• The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion.

  2026cites this paper
• Knock-in reporter constructs and drug screening for compounds to restore RKIP expression in cancer.

  2026cites this paper
• ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor Microenvironment.

  2026cites this paper
• RKIP and tumor immune evasion: Remodeling the immunosuppressive tumor microenvironment.

  2025cites this paper
• Roles of tumor-associated macrophages in triple-negative breast cancer progression

  2025cites this paper
• Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment

  2025cites this paper
• Pan-Cancer Computational Analysis of RKIP (PEBP1) and LKB1 (STK11) Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment

  2025cites this paper
• RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

  2025cites this paper
• Tumor Immune Engineering: Developing In Vitro Assays to Understand the Tumor–Immune Crosstalk

  2025cites this paper
• Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention

  2025cites this paper
• Tumor necrosis factor receptor 2 in allergen tolerance: a perspective view

  2025cites this paper
• Scaffolding Protein ENH Promotes Tumor Angiogenesis and Growth Through Macrophage Recruitment and Polarization

  2025cites this paper
• Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma

  2025cites this paper
• Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

  2025cites this paper
• Organotropic metastasis in colorectal cancer: integrating molecular pathways with therapeutic opportunities

  2025cites this paper
• The implied dysregulated RKIP-hypoxia axis in cancer and immune evasion: Clinical implications.

  2025cites this paper
• Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment

  2024cites this paper
• Synergistic Target‐Attacking Tumor Cells and M2 Macrophages via a Triple‐Responsive Nanoassembly for Complete Metastasis Blocking

  2024cites this paper
• Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis

  2024cites this paper
• Cold and hot tumors: from molecular mechanisms to targeted therapy

  2024cites this paper
• Circulating RKIP and pRKIP in Early-Stage Lung Cancer: Results from a Pilot Study

  2024cites this paper
• Synergistic approach to combating triple-negative breast cancer: DDR1-targeted antibody-drug conjugate combined with pembrolizumab

  2024cites this paper
• Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma Patients

  2024cites this paper
• Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy

  2024cites this paper
• C–C Motif Chemokine Ligand 5 (CCL5) as a Predictive Marker for Non-sentinel Lymph Node Presence in Initial-Stage Breast Cancer with 1–2 Affected Sentinel Lymph Nodes

  2024cites this paper
• Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications

  2024cites this paper
• Changes in Expression of Tumor Suppressor Gene RKIP Impact How Cancers Interact with Their Complex Environment

  2023influential citation
• RSK4 promotes the macrophage recruitment and M2 polarization in esophageal squamous cell carcinoma.

  2023cites this paper
• How chemokines organize the tumour microenvironment

  2023influential citation
• Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy

  2023cites this paper
• A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation

  2023cites this paper
• Low-dose TNF-α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2/Akt/mTOR axis.

  2023cites this paper
• Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis

  2023cites this paper
• Subverted macrophages in the triple-negative breast cancer ecosystem.

  2023cites this paper
• Cancer-associated immune cells and their modulation by melatonin

  2023cites this paper
• ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.

  2023cites this paper
• Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment

  2023cites this paper
• Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer

  2022cites this paper
• Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy.

  2022cites this paper
• The Innate Immune Microenvironment in Metastatic Breast Cancer

  2022influential citation
• Macrophages-aPKCɩ-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma

  2022cites this paper
• The role of tumor-associated macrophages in oral squamous cell carcinoma

  2022cites this paper
• The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy

  2022influential citation
• Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer

  2022cites this paper
• Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

  2022cites this paper
• Targeting TNFR2 in Cancer: All Roads Lead to Rome

  2022cites this paper
• The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart

  2022cites this paper
• Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression

  2022cites this paper
• Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment

  2021cites this paper
• Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study

  2021cites this paper
• Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy

  2021cites this paper
• Phosphatidylethanolamine binding protein 1 enhances sensitivity of gastric cancer cell to 5-fluorouracil via inhibition of cell proliferation, migration and invasion

  2021cites this paper
• Key chemokines direct migration of immune cells in solid tumors

  2021cites this paper
• HMGA2 as a Critical Regulator in Cancer Development

  2021cites this paper
• The prospects of Nanotherapeutic approaches for targeting Tumor-Associated Macrophages in oral cancer.

  2021cites this paper
• Chemokines and the immune response to cancer.

  2021cites this paper
• Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

  2021cites this paper
• Inflammation and tumor progression: signaling pathways and targeted intervention

  2021cites this paper
• The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies

  2021cites this paper
• Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5

  2021influential citation
• The RhoA dependent anti-metastatic function of RKIP in breast cancer

  2021cites this paper
• The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response

  2021cites this paper
• Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy.

  2021cites this paper
• Maraviroc Prevents HCC Development by Suppressing Macrophages and the Liver Progenitor Cell Response in a Murine Chronic Liver Disease Model

  2021cites this paper
• Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy

  2021influential citation
• Macrophages-aPKCɩ-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma

  2021cites this paper
• Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?

  2021cites this paper
• Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

  2021cites this paper
• Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies

  2021cites this paper
• Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles.

  2020cites this paper
• Theranostic role of RKIP in cancer

  2020cites this paper
• Role of RKIP in inflammatory responses

  2020cites this paper
• The G protein coupled receptor CCR5 in cancer.

  2020cites this paper
• CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes

  2020cites this paper
• RNA Nanotechnology-Mediated Cancer Immunotherapy

  2020cites this paper
• B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.

  2020cites this paper
• Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies

  2020cites this paper
• The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

  2020cites this paper
• The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative

  2020cites this paper
• Emerging roles for HMGA2 in colorectal cancer

  2020cites this paper
• Yin-yang effect of tumour cells in breast cancer: from mechanism of crosstalk between tumour-associated macrophages and cancer-associated adipocytes.

  2020cites this paper
• Anti-cancer effect of RKIP via modulating autophagy during metastasis

  2020cites this paper
• Radiotherapy Increases 12-LOX and CCL5 Levels in Esophageal Cancer Cells and Promotes Cancer Metastasis via THP-1-Derived Macrophages

  2020cites this paper
• Pleiotropic activities of RKIP in cancer: Role in survival, EMT, chemo-immuno-resistance, and autophagy

  2020cites this paper
• Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy

  2020cites this paper
• IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer

  2019cites this paper
• RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer

  2019influential citation
• Macrophage Flipping from Foe to Friend: A Matter of Interest in Breast Carcinoma Heterogeneity Driving Drug Resistance.

  2019cites this paper
• Toward Normalization of the Tumor Microenvironment for Cancer Therapy

  2019influential citation
• Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy

  2019cites this paper
• Recent Advances targeting CCR5 for Cancer and its Role in Immuno-Oncology.

  2019cites this paper
• RKIP mediates autoimmune inflammation by positively regulating IL‐17R signaling

  2018cites this paper
• Natural small molecule bigelovin suppresses orthotopic colorectal tumor growth and inhibits colorectal cancer metastasis via IL6/STAT3 pathway

  2018cites this paper
• Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma

  2018cites this paper
• New Insights into the Tumor Microenvironment Utilizing Protein Array Technology

  2018influential citation
• SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.

  2018cites this paper
• Tumor extracellular vesicles are required for tumor-associated macrophage programming

  2018cites this paper
• Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors

  2018cites this paper
• Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway

  2018cites this paper
• Targeting Raf Kinase Inhibitory Protein Regulation and Function

  2018cites this paper